Using What You've Got
Malaria Vaccine, via 'Mosquito Bioreactors,' May be in View
By Anette Breindl
Friday, September 9, 2011
In work that has moved from the lab to the clinic and back, and is now poised to enter the clinic yet again, researchers have figured out how to manufacture and administer what they believe is the first highly effective malaria vaccine one that can provide protection lasting at least six to 24 months to 80 percent of those vaccinated.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.